Search for a funded project
Alliance between UBO and Guerbet for Research in Oncology and Radiopharmaceutical Advancements. – AURORA
The AURORA Joint Laboratory (Alliance UBO-Guerbet for Research in Oncology and Advanced Radiopharmaceuticals) [...] initiative between the University of Western Brittany (UBO) and Guerbet SA, aimed at developing innovative [...] Leveraging the recognized expertise of the UMR CNRS-UBO 6521 CEMCA laboratory in macrocyclic ligand design
LabexMER Marine Excellence Research: a changing ocean
recherche (UMR) associant l’Université de Brest (UBO) et, selon les unités, le CNRS, l’IRD, l’UN et/ou
Towards real-time monitoring of Bacillus thuringiensis biopesticides production using laser Speckle imaging within a Mediterranean area network – BIOSMAN
biology from three Mediterranean countries: France (UBO), Lebanon (USJ) and Tunisia (CBS).
Compact circulator operating in Ku band – CirCKu
Lab-STICC which is common to the University of Brest (UBO) and the school of engineers IMT Atlantique. It revolves
Promotion of local Mediterranean fermented foods through a better knowledge and management of microbial resources – ProMedFoods
Tunisia, ENSAT) and 4 EU countries (France, INRA and UBO, Greece, DEMETER, Italy, DISAFA and Spain, IPLA)
Advanced chelators for innovative diagnosis technologies – ACHETE
Coordination chemistry for the diagnosis of cancer and rare diseases
LIving together in the Future: vulnErability of DEEP sea Ecosystems facing potential mineral Resources exploitation
richesses minérales. Notre consortium (Ifremer, UBO, SU, IRD, MNHN et CNRS) porte une série de cinq campagnes
Formation en Numérique pour la Santé et la Médecine 5P par l'innovation
CHRU de Brest, Université de Bretagne Occidentale (UBO), groupement SIB, groupements professionnels ASINPHA
Optimiser l'entraînement mental pour atteindre l'or olympique, approche psycho-physiologique innovantes de la performance en escrime
(FFE), les universités de Bretagne Occidentale (UBO), de Claude Bernard Lyon 1 (UCBL), de Paris Nanterre
Impact of LUng MIcrobiota in vascular remodeling and pulmonary arterial hypertension: potential for innovative biotherapeutic target – LUMI
, P2 (MICALIS-INRA), and P3 (INSERM UMR_S 1078, UBO), respectively in the fields of Biology/Medicine